Table 2. Microarray analysis of endometria during the window phase of three groups.
| Patient ID | Age (year) | Infertility Duration (year) | Cause of infertility | IVF/ICSI | BMI | Study group | Time of biopsy |
|---|---|---|---|---|---|---|---|
| 1 | 25 | 2 | Fallopian tube blockages | IVF | 18.9 | untreated | LH + 7 |
| 2 | 31 | 5 | Oligospermia | ICSI | 22.5 | untreated | LH + 7 |
| 3 | 32 | 3 | Oligospermia | ICSI | 20.8 | untreated | LH + 7 |
| 4 | 29 | 2 | Oligospermia | ICSI | 21.1 | GnRH antagonist | 7 days after opu |
| 5 | 27 | 4 | Fallopian tube blockages | IVF | 23.0 | GnRH antagonist | 7 days after opu |
| 6 | 35 | 5 | Fallopian tube blockages | IVF | 19.7 | GnRH antagonist | 7 days after opu |
| 7 | 24 | 1 | Oligospermia | ICSI | 24.2 | GnRH agonist | 7 days after opu |
| 8 | 31 | 5 | Fallopian tube blockages | IVF | 22.0 | GnRH agonist | 7 days after opu |
| 9 | 27 | 3 | Fallopian tube blockages | IVF | 24.2 | GnRH agonist | 7 days after opu |
The control subjects had natural cycles with no treatment, and endometrial biopsies were obtained on day 7 after ovulation. For the GnRH antagonist and long agonist groups, endometrial biopsies were obtained on day 7 after oocyte recovery.